title: Glaucoma neuroprotection: What is it? Why is it needed?
abstract: The glaucomas are a group of ocular diseases characterized by progressive optic nerve damage and visual loss. Although there is good laboratory evidence for glaucoma neuroprotection by several drugs, the evidence from randomized clinical trials is lacking.
authors.affiliation: Hamilton Glaucoma Center, University of California, San Diego, USA. weinreb@eyecenter.ucsd.edu
authors.forename: Robert N
authors.initials: RN
authors.lastname: Weinreb
mesh_terms: D000818:Animals; D005901:Glaucoma / Q000517:prevention & control*; D006801:Humans; D018696:Neuroprotective Agents / Q000494:pharmacology*; D009901:Optic Nerve Diseases / Q000517:prevention & control*; D012165:Retinal Ganglion Cells / Q000187:drug effects*; D014795:Visual Pathways / Q000187:drug effects*
chemical_list: D018696:Neuroprotective Agents